Search

everythinglearnresearchcommunity

for

Search:↓

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Testosterone may slow down wound healing and increase inflammation.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

A 12-year-old girl with very high testosterone and insulin resistance improved with birth control pills, suggesting PCOS can cause high testosterone without tumors.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.